Alzamend Neuro, Inc. (ALZN)
↓ Download CSVKey ratios (FY2026)
-1196.4%
Return on equity
| Metric (FY) | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Income | -$8.77M | -$4.50M | -$9.94M | -$14.87M | -$12.32M | -$4.95M | -$4.42M | — |
| Net Income | -$8.77M | -$4.51M | -$9.95M | -$14.88M | -$12.36M | -$5.05M | -$4.41M | — |
| EPS (Diluted) | $-2.63 | $-11.32 | $-132.33 | $-22.89 | $-0.14 | — | — | — |
| Total Assets | $2.08M | $4.60M | $631.6K | $5.92M | $14.52M | $2.91M | $1.81M | — |
| Total Liabilities | $1.35M | $634.8K | $3.23M | $2.87M | $1.16M | $899.6K | — | — |
| Shareholders' Equity | $733.2K | $3.97M | -$2.59M | $3.05M | $13.35M | $2.01M | $821.7K | $316.9K |
| Cash & Equivalents | $710.7K | $3.95M | $376.0K | $5.14M | $14.06M | $1.93M | $90.3K | $42.6K |
| Operating Cash Flow | -$8.07M | -$6.57M | -$8.27M | -$8.92M | -$6.61M | -$2.71M | -$2.35M | — |
| Shares Outstanding | 4.26M | 778.7K | 76.4K | 646.3K | 95.48M | 67.43M | 64.76M | — |